DanCann Pharma A/S (NGM:DANCAN)
Sweden · Delayed Price · Currency is SEK · Price in DKK 0.9800
+0.0450 (4.81%)
At close: Jul 21, 2025
DanCann Pharma Revenue
DanCann Pharma had revenue of 244.00K DKK in the quarter ending March 31, 2025, a decrease of -65.24%. This brings the company's revenue in the last twelve months to 6.91M, up 1.19% year-over-year. In the year 2024, DanCann Pharma had annual revenue of 7.37M with 3.06% growth.
Revenue (ttm)
6.91M DKK
Revenue Growth
+1.19%
P/S Ratio
0.61
Revenue / Employee
1.38M DKK
Employees
5
Market Cap
6.16M SEK
Revenue Chart
* This company reports financials in DKK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 85.17B |
| Atlas Copco AB | 173.03B |
| AB Volvo | 500.08B |
| EQT AB | 30.08B |
| ASSA ABLOY AB | 152.95B |
| Skandinaviska Enskilda Banken AB | 78.55B |
| Sandvik AB | 121.46B |
| Swedbank AB | 72.19B |